Parathyroid hormone and raloxifene for increasing bone mass
AssigneeEli Lilly and Company
InventorJanet M. Hock
Life of this patent
Estimating the term…
Abstract
The present invention includes a method for increasing bone mass in a subject by administration of PTH and raloxifene. Another aspect of the invention is a method for treating bone loss in a subject by administration of PTH and raloxifene. The invention further provides for a composition of PTH and raloxifene for increasing bone mass in a subject. Another aspect of the invention is a composition of PTH and raloxifene for treatment of bone loss in a subject.
Claims12
A method for increasing bone mass in a subject, comprising administering a pharmaceutically effective dose of PTH and a pharmaceutically effective dose of raloxifene, to the subject.
A method for treating bone loss in a subject, comprising administering a pharmaceutically effective dose of PTH and a pharmaceutically effective dose of raloxifene to the subject.
A composition for increasing bone mass in a subject, comprising a pharmaceutically effective dose of PTH and a pharmaceutically effective dose of raloxifene in a pharmaceutically acceptable excipient.
A composition for treating bone loss in a subject, comprising a pharmaceutically effective dose of PTH and a pharmaceutically effective dose of raloxifene in a pharmaceutically acceptable excipient.
Dependencies are inferred from the claim text.